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In recent years, sarcopenia in the elderly has been in focus. The 
Asian Working Group for Sarcopenia (AWGS) defined sarcopenia 
as age-related loss of muscle mass, plus low muscle strength, and/or 
low physical performance [1]. It is related to several factors such as 
low physical function, BMI, android fat, albumin and so on [2]. For 
the therapy of sarcopenia, there have been main methods of lifestyle 
interventions, nutritional supplementation and exercise for years [1]. 
Among the elderly living in the residence area, the prevalence of 
malnutrition and sarcopenia has been estimated to be about 10%, 
respectively [3,4]. Most of the independent elderly people who can 
walk and visit the outpatient department do not usually have these 
problems. Then, this is the group that we aim to prevent the onset of 
sarcopenia with maintaining good nutrition. For these people, there 
was no intervention studies that attempted to prevent sarcopenia with 
nutritional guidance alone [5]. On the other hand, investigation would 
be necessary for people with sarcopenia from nutritional point of view.
A cross-sectional study found that the prevalence of sarcopenia in 
men was associated with lack of dietary diversity in Japanese (n=1074) 
[5]. In a study of elderly Asian women, the amount of protein intake 
was divided into 4 groups, and skeletal musclemass was increased in 
the group with high intake of protein [6]. Protein intake amount in 
median and the third quartile were 0.96 g / kg / day and 1.18 g / kg / day, 
respectively. In another study, a protein intake was 1.2 g/kg/day in an 
intervention study in which skeletal muscle mass was increased in obese 
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people with sarcopenia [5]. Based on the above, it is recommended to 
take 1.0 g/kg/day or more of protein per proper weight.
There was a study to explore the association of malnutrition and 
sarcopenia, according to the guidelines Global Leadership Initiative 
of Malnutrition (GLIM), European Society of Clinical Nutrition and 
Metabolism (ESPEN) and European Working Group on Sarcopenia in 
Older People 2 (EWGSOP2) [4]. A significantly higher risk was found 
during 4-year follow-up. As the results of adjusted Hazard Ratio (aHR), 
GLIM showed 3.23 for sarcopenia, 2.87 for severe sarcopenia, and 
ESPEN showed 4.28 for sarcopenia and 3.86 is for severe sarcopenia [4].
Several multiple cross-sectional studies were present concerning 
the relationship between frailty and undernutrition [7,8]. Among 
these, the evaluation for nutritional condition was conducted by the 
Mini Nutritional Assessment (MNA) [7,8].
In order to study the relationship among several factors, elder frailty 
patients of University hospital in Rome were evaluated [9]. They were 
multidimensional geriatric evaluations, such as MNA, Activity of Daily 
Living (ADL), Instrumental Activity of Daily Living (IADL), Mini–
Mental State Examination (MMSE), Geriatric Depression Scale (GDS), 
Cumulative Illness Rating Scale for Geriatrics (CIRS-G), Survey of 
Health, Ageing and Retirement in Europe-Frailty Index (SHARE-FI)
[9]. Thus, sarcopenia has been evaluated from multiple points of view.
Older people with sarcopenia are more likely to have malnutrition. 
In addition to aging, causes of sarcopenia include underactivity, 
malnutrition, illness, hospitalization, medicines and so on [10]. The 
effectiveness of nutritional intervention depends on the presence or 
cause of the undernutrition. Therefore, it is necessary to identify causes 
other than malnutrition. To date, there have been no intervention trials 
of nutritional therapy alone for the elder patients with sarcopenia. 
However, improvement of sarcopenia by a combination of nutrition 
therapy and exercise therapy has been reported [11].
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In addition to the administration of protein, vitamin D, 
micronutrients with antioxidant action, and Polyunsaturated Fatty 
Acid (PUFA) with anti-inflammatory action are also found as factors 
related to malnutrition [12]. However, there are still many problems to 
be solved such as the daily intake, timing, long-term effect, and others 
[13]. Research on proper usage and dosage of nutrients involved in 
sarcopenia treatment will be expected in the future.
After the diagnosis of sarcopenia, the important point would 
be to consider the treatment goals. Should it be recovered, can it be 
recovered, or can it not be recovered? [1-3].
The first is iatrogenic matters in relation to hospitalization, drugs 
and lack of care. The second is due to low activity and malnutrition, 
which may be reversible if activity improves and nutrient intake returns 
to normal levels. Third, there are cases where the underlying diseases 
are malignant tumors, cachexia, chronic inflammatory diseases, and 
neuromuscular diseases [1,2,5]. In these cases, it is difficult to improve 
or cure the original diseases, so that recovery seems to be also difficult. 
Therefore, try to intervene so as to delay the progression of sarcopenia 
as much as possible.
The above is the principle, but in actual clinical practice, there 
are many overlapped cases. It is necessary to examine the contents 
according to each case and to carry out nutritional intervention.
Protein occupies most of the components of skeletal muscle. It is the 
most influential nutrient in the treatment of sarcopenia. In particular, 
essential amino acids cannot be synthesized in the body, and then 
sufficient amount should be provided for skeletal muscle synthesis [14]. 
Of the essential amino acids, three types of branched chain amino 
acids (BCAA), namely valine, leucine, and isoleucine, are important. 
These materials can synthesize skeletal muscle, become also an 
energy source, and have an inhibitory effect on the decomposition of 
muscle protein [15].
Among them, leucine can be especially expected to increase 
skeletal muscle. In the metabolism of the cells, leucine activates 
the mammalian Target of Rapamycin (mTOR) system pathway to 
promote protein synthesis. It also contributes to activation of the 
entire cell growth promoting pathway via insulin. However, it has 
been reported that the concentration of valine and isoleucine in 
blood would be decreased when leucine alone is administered [16]. 
Therefore, administration of BCAA rich in leucine may be effective for 
various clinical cases [17].
Dietary protein provides amino acids that can be used for protein 
synthesis. Following ingestion, dietary protein is digested and absorbed. 
It is found before dietary protein-derived amino acids become available 
in circulation [18]. Amino acids are subsequently available to peripheral 
tissues including skeletal muscle.
Nutritional guidance for the elderly may be divided into two cases. 
One is for the elderly without sarcopenia. Recommended diet is to 
increase protein intake based on the energy intake required to maintain 
the present status. Another is for elderly people with sarcopenia, in 
which personalized nutritional support would be necessary. First, the 
nutritional status and the causes of sarcopenia would be evaluated. 
Second, eliminate the cause and approach nutrition therapy together. 
Third, a target energy amount is set, a nutrition amount is secured, and 
nutritional intervention will be performed so that larger amount of 
BCAA can be taken.
In summary, the prevention and treatment of sarcopenia are 
cannot be completed only by the physician. Multidisciplinary 
interventions related to sarcopenia-related activities, nutrition, illness, 
hospitalization, and medicine will be required.
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